Clene recently announced top-line data from RESCUE-ALS, a Phase 2 clinical trial evaluating CNM-Au8 as a disease modifying treatment for people with early amyotrophic lateral sclerosis (ALS).
Wilson Sonsini Goodrich & Rosati to open an office in Salt Lake City, becoming the latest major U.S. law firm to plant a flag in the tech-heavy region sometimes called “Silicon Slopes.”
Myriad Genetics announced financial results for its third quarter ended September 30, 2021 and provided an update on recent business performance and strategic transformation plans.
12 new hydrophilic-coated micro and support catheters cleared by FDA for broad use in the peripheral vasculature.
Utah has now become a VC darling with a maturing ecosystem complete with angels, seed-stage, growth stage, and private equity investors, says Brad Plothow, VP of strategy at St. George aerospace startup Intergalactic.
Fluidx Medical’s GPX Embolic Device Releases Initial Results for Oncology Drug Delivery
Home to the cutting-edge equipment and premier learning opportunities students need to meet workforce demand upon graduation, Dixie State University’s Science, Engineering & Technology Building was dedicated during a special Homecoming Week ceremony.
University of Utah Research Park was host to the 2021 International Conference of the Association of University Research Parks from October 18-21, 2021. The opening “campfire” was held at Red Butte Amphitheater on the afternoon of October 19. Speakers included new University of Utah President, Taylor Randall and Dean Peter Trapa of the College of […]
By: Joe Spillner of Squire Historically, there has been a terrific tax incentive for noncorporate taxpayers to invest in small businesses granted under section 1202 of the Internal Revenue Code. More commonly known as Qualified Small Business Stock (“QSBS”) gain exclusion, section 1202 provides noncorporate taxpayers the opportunity to exclude 100% of any gain on a […]
Udo announced the official launch of its new video-based healthcare collaboration app.
Bauer explains the two key factors he looks at when determining whether a medical device company is worth trying to turn around and more.
BIOMERICS Expands Micro Metal Processing Capabilities In Silicon Valley and CT Areas